Infertility, postmenopausal osteoporosis, Polycystic Ovary Syndrome (PCOS), and endometriosis are some of the major problems women face during their lifetime. For instance, according to the International Osteoporosis Foundation, global prevalence of osteoporosis among women was over 200.0 million in 1990, and this is anticipated to reach 680.0 million in 2050.
Healthcare companies and academic and research institutes have been investing in R&D and commercialization of drugs that can treat a multitude of women’s health issues. For instance, in February 2018, a new company named Theramex launched by CVC Capital Partners. The company focuses on a broad range of women’s health products such as fertility, contraception, menopause, and osteoporosis and will market them around the 50 countries. [Read more…]